Technology-Based Primary Care Support to Improve Blood Pressure Before Pregnancy
Tests a technology-based care approach for women with hypertension who may become pregnant.
Key facts
- Who runs it
- Northwestern University
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- The REACH-OUT Trial
- Status
- Recruiting
- People taking part
- 350 people, planned
- Started
- 16 Jun 2026
- Expected to end
- 30 Jun 2030
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Health literacy-informed patient education materials
- BP monitor, brief orientation, and portal tools
- The MeDS assessment
- Patient navigator support
- Record updated
- 9 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18-44 with high blood pressure who take a blood pressure medicine and have a high reading at their visit.
- Age
- 18-44 years
- Sex
- Women (biologically female)
- Disease stage
- High blood pressure: systolic (top number) above 140 or diastolic (bottom number) above 90 at the index visit.
- Earlier treatment
- Must be prescribed a blood pressure medicine (antiHTN).
Main reasons for not taking part
- Pregnant or within 3 months after giving birth
- Severe vision, hearing or thinking problems that cannot be corrected and would stop consent or taking part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- biologically female
- age 18-44
- English or Spanish-speaking
- prescribed an antiHTN
- have a systolic BP >140 or diastolic BP>90 at their index visit
- have access to the internet
Who cannot take part
- severe, uncorrectable vision, hearing, or cognitive impairment that would preclude study consent or participation
- not pregnant or within 3 months postpartum
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 44 years old?
Where in United States
- Northwestern UniversityChicago, United StatesContact: Guisselle Wismer, MPHTaking people
About the trial
What the trial wants to find out
Test the effectiveness of a technology-enabled strategy to optimize blood pressure among reproductive-aged women with hypertension receiving care in Federally Qualified Health Centers.
The 2 groups in the trial
- REACH-OUTTreatment being tested
In addition to the CDS and home blood pressure monitor that usual care patients receive, REACH-OUT patients will receive \[1\] health literacy-informed patient education materials, \[2\] orientation to using the blood pressure monitor and portal tools, \[3\] the MeDS assessment, and \[4\] patient navigator support if needed.
Treatment: Health literacy-informed patient education materials, BP monitor, brief orientation, and portal tools, The MeDS assessment, and Patient navigator support
- Usual CareNo study treatment, for comparison
Clinical decision support (CDS) will be embedded in the EHR. CDS will be triggered during all routine primary care visits for eligible patients who are seeing a physician or Advanced Practice Provider. CDS will prompt clinicians to review prescribed antiHTNs and contraceptives to identify any contraindications and to counsel patients on the importance of antiHTN adherence and BP control for reproductive-aged women.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Technology-based, Primary Care Strategy to Optimize Blood Pressure Before Pregnancy: The REACH-OUT Trial
- Plain-language title
- Technology-Based Primary Care Support to Improve Blood Pressure Before PregnancyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07540143, who can take part
- Record updated
- 9 November 2026